These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 24042110)

  • 1. Protective humoral immunity elicited by a needle-free malaria vaccine comprised of a chimeric Plasmodium falciparum circumsporozoite protein and a Toll-like receptor 5 agonist, flagellin.
    Carapau D; Mitchell R; Nacer A; Shaw A; Othoro C; Frevert U; Nardin E
    Infect Immun; 2013 Dec; 81(12):4350-62. PubMed ID: 24042110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced immunogenicity of Plasmodium falciparum peptide vaccines using a topical adjuvant containing a potent synthetic Toll-like receptor 7 agonist, imiquimod.
    Othoro C; Johnston D; Lee R; Soverow J; Bystryn JC; Nardin E
    Infect Immun; 2009 Feb; 77(2):739-48. PubMed ID: 19047411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin scarification with Plasmodium falciparum peptide vaccine using synthetic TLR agonists as adjuvants elicits malaria sporozoite neutralizing immunity.
    Mitchell RA; Altszuler R; Frevert U; Nardin EH
    Sci Rep; 2016 Sep; 6():32575. PubMed ID: 27624667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge.
    Calvo-Calle JM; Oliveira GA; Watta CO; Soverow J; Parra-Lopez C; Nardin EH
    Infect Immun; 2006 Dec; 74(12):6929-39. PubMed ID: 17030584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG2 antibodies against a clinical grade Plasmodium falciparum CSP vaccine antigen associate with protection against transgenic sporozoite challenge in mice.
    Schwenk R; DeBot M; Porter M; Nikki J; Rein L; Spaccapelo R; Crisanti A; Wightman PD; Ockenhouse CF; Dutta S
    PLoS One; 2014; 9(10):e111020. PubMed ID: 25343487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sporozoite neutralizing antibodies elicited in mice and rhesus macaques immunized with a Plasmodium falciparum repeat peptide conjugated to meningococcal outer membrane protein complex.
    Przysiecki C; Lucas B; Mitchell R; Carapau D; Wen Z; Xu H; Wang XM; Nahas D; Wu C; Hepler R; Ottinger E; Ter Meulen J; Kaslow D; Shiver J; Nardin E
    Front Cell Infect Microbiol; 2012; 2():146. PubMed ID: 23226683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of protective immune responses induced by the Plasmodium falciparum circumsporozoite protein-based, self-assembling protein nanoparticle vaccine.
    McCoy ME; Golden HE; Doll TA; Yang Y; Kaba SA; Zou X; Gerbasi VR; Burkhard P; Lanar DE
    Malar J; 2013 Apr; 12():136. PubMed ID: 23607541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts.
    Birkett A; Lyons K; Schmidt A; Boyd D; Oliveira GA; Siddique A; Nussenzweig R; Calvo-Calle JM; Nardin E
    Infect Immun; 2002 Dec; 70(12):6860-70. PubMed ID: 12438363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-assembling protein nanoparticles with built-in flagellin domains increases protective efficacy of a Plasmodium falciparum based vaccine.
    Kaba SA; Karch CP; Seth L; Ferlez KMB; Storme CK; Pesavento DM; Laughlin PY; Bergmann-Leitner ES; Burkhard P; Lanar DE
    Vaccine; 2018 Feb; 36(6):906-914. PubMed ID: 29269157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primates.
    Tewari K; Flynn BJ; Boscardin SB; Kastenmueller K; Salazar AM; Anderson CA; Soundarapandian V; Ahumada A; Keler T; Hoffman SL; Nussenzweig MC; Steinman RM; Seder RA
    Vaccine; 2010 Oct; 28(45):7256-66. PubMed ID: 20846528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P. falciparum and P. vivax Epitope-Focused VLPs Elicit Sterile Immunity to Blood Stage Infections.
    Whitacre DC; Espinosa DA; Peters CJ; Jones JE; Tucker AE; Peterson DL; Zavala FP; Milich DR
    PLoS One; 2015; 10(5):e0124856. PubMed ID: 25933001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective antibody and CD8+ T-cell responses to the Plasmodium falciparum circumsporozoite protein induced by a nanoparticle vaccine.
    Kaba SA; McCoy ME; Doll TA; Brando C; Guo Q; Dasgupta D; Yang Y; Mittelholzer C; Spaccapelo R; Crisanti A; Burkhard P; Lanar DE
    PLoS One; 2012; 7(10):e48304. PubMed ID: 23144750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies elicited by Plasmodium falciparum circumsporozoite proteins lacking sequentially deleted C-terminal amino acids reveal mouse strain and epitopes specific differences.
    Hayashi CTH; Cao Y; Zavala F; Simonyan H; Young CN; Kumar N
    Vaccine; 2023 Nov; 41(46):6824-6833. PubMed ID: 37827967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmodium falciparum synthetic LbL microparticle vaccine elicits protective neutralizing antibody and parasite-specific cellular immune responses.
    Powell TJ; Tang J; Derome ME; Mitchell RA; Jacobs A; Deng Y; Palath N; Cardenas E; Boyd JG; Nardin E
    Vaccine; 2013 Apr; 31(15):1898-904. PubMed ID: 23481177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver-Directed AAV8 Booster Vaccine Expressing
    Shahnaij M; Iyori M; Mizukami H; Kajino M; Yamagoshi I; Syafira I; Yusuf Y; Fujiwara K; Yamamoto DS; Kato H; Ohno N; Yoshida S
    Front Immunol; 2021; 12():612910. PubMed ID: 34248928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection.
    Cummings JF; Spring MD; Schwenk RJ; Ockenhouse CF; Kester KE; Polhemus ME; Walsh DS; Yoon IK; Prosperi C; Juompan LY; Lanar DE; Krzych U; Hall BT; Ware LA; Stewart VA; Williams J; Dowler M; Nielsen RK; Hillier CJ; Giersing BK; Dubovsky F; Malkin E; Tucker K; Dubois MC; Cohen JD; Ballou WR; Heppner DG
    Vaccine; 2010 Jul; 28(31):5135-44. PubMed ID: 19737527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing blood-stage malaria subunit vaccine immunogenicity in rhesus macaques by combining adenovirus, poxvirus, and protein-in-adjuvant vaccines.
    Draper SJ; Biswas S; Spencer AJ; Remarque EJ; Capone S; Naddeo M; Dicks MD; Faber BW; de Cassan SC; Folgori A; Nicosia A; Gilbert SC; Hill AV
    J Immunol; 2010 Dec; 185(12):7583-95. PubMed ID: 21098232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
    Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-Dependent, Gamma Interferon-Independent Sterilizing Immunity Induced by a Subunit Malaria Vaccine.
    Chawla B; Mahajan B; Oakley M; Majam VF; Belmonte A; Sedegah M; Shimp RL; Kaslow DC; Kumar S
    Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31308085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging murine NALT following intranasal immunization with flagellin-modified circumsporozoite protein malaria vaccines.
    Nacer A; Carapau D; Mitchell R; Meltzer A; Shaw A; Frevert U; Nardin EH
    Mucosal Immunol; 2014 Mar; 7(2):304-14. PubMed ID: 23820750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.